Kindred Health Inc., a pioneering femtech (female reproductive health technology) company in the Philippines said Thursday it secured $5.5 million in pre-Series A funding to transform women’s health in the country.
The funding comprised an initial tranche of $2.5 million with an additional $3 million secured in commitments contingent upon achieving key milestones.
Beginning with a virtual clinic during the pandemic, Kindred went on to open a physical clinic in Taguig City in 2023 to better meet the needs of its clients. It teamed up with more than 70 doctors across 25 sub-categories to offer consultations with trusted specialists from OBGyn to mental health, contraceptives, health screenings, immunizations, IV therapy, nutrition and fitness coaching as well as other wellness services.
“We are deeply grateful to our investors for their trust and belief in our mission. This will enable us to scale our services, improve our technology, and increase our capacity to better serve our clients, paving the way for future generations of women in the Philippines,” said Jessica de Mesa-Lim, co-founder and chief executive of Kindred.
Launched in 2021, Kindred has rapidly established itself as a leader in the healthcare and femtech sectors by offering accessible, affordable and elevated healthcare services for women.
It launched a web-based telehealth service and built a strong social media community in 2022. By 2023, Kindred raised $1 million in seed funding, opened its first clinic and introduced the Kindred mobile app.
The funding round was led by Integra Partners, with participation from key investors including Kaya Founders, KSR Ventures, Ava Zobel Pessina, Pawikan Capital Group, Tenco Capital and individuals such as Dr. Frans Beltran and Micaela Beltran.
Pulse63 Healthcare Ventures continues to play a crucial role in guiding the company’s strategic direction and growth, demonstrating unwavering support for Kindred’s mission.
“At Integra, we believe that women’s health is a huge market opportunity in Southeast Asia and globally, especially as the healthcare industry starts to gain a deeper understanding of how women manifest different symptoms and respond to treatments differently across a range of diseases and conditions,” said Jennifer Ho, partner at Integra Partners.
“It’s been a privilege to work with Jess to map out the future of Kindred and how it can serve this burgeoning market,” she said.
Be the first to comment